Unfortunately, given the gestational variability in insulin sensitivity and absorption, achieving and maintaining tight glycaemic control in pregnancy is often difficult to accomplish, even with increasing use of new diabetes technologies including continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII, insulin pumps) [6–9]. Here, INS is linked to diabetes mellitus.